Kawasaki, Japan

Taisuke Ichimaru


 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Taisuke Ichimaru: Innovator in Oligonucleotide Synthesis

Introduction

Taisuke Ichimaru is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of oligonucleotide synthesis, holding a total of seven patents. His work focuses on innovative methods that enhance the efficiency and purity of oligonucleotide production.

Latest Patents

Ichimaru's latest patents include groundbreaking processes for the synthesis of oligonucleotides. One notable patent describes a convergent liquid phase process for manufacturing oligonucleotides by coupling two or more oligonucleotide fragments, each containing two or more nucleotides. This method streamlines the production process and improves overall efficiency. Another patent outlines a method for producing oligonucleotides that involves removing a temporary protecting group of a 5'-hydroxyl group. This is achieved by adding an acid to a protected oligonucleotide, which can significantly enhance condensation yields while reducing impurities.

Career Highlights

Throughout his career, Taisuke Ichimaru has worked with notable companies such as Ajinomoto Co., Ltd. and Ea Pharma Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative techniques in oligonucleotide synthesis.

Collaborations

Ichimaru has collaborated with several talented individuals in his field, including Daisuke Takahashi and Takahiro Koshiba. These collaborations have contributed to the advancement of research and development in oligonucleotide technologies.

Conclusion

Taisuke Ichimaru is a distinguished inventor whose work in oligonucleotide synthesis has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to improving production methods and enhancing the quality of oligonucleotides.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…